Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral: Vanier Canada Graduate Scholarships

McGill University

$150,000.00

Dissecting the role of the poly(C)-binding protein 2 in the hepatitis C virus life cycle

FY 2015-16

Summary
Viruses produce more copies of themselves by taking over the molecular machinery of their host cells. The hepatitis C virus (HCV), which infects an estimated 268 000 Canadians, is no exception. While we know that HCV uses components of human liver cells (i.e. cellular proteins and microRNAs) to promote its own replication and to protect itself from molecular defences against viruses, the precise mechanisms behind many of these interactions are still unknown. This project aims to clarify the role of a particular cellular protein, the poly(C)-binding protein 2 (PCBP2), in the HCV life cycle. HCV is known to co-opt this protein, but it is unclear how PCBP2 helps the virus to accumulate. We aim to understand: At which stage(s) of the virus life cycle does PCBP2 play a role? How does it interact with other cellular elements that we know HCV uses to produce more viruses - specifically, is this a collaboration or a competition? Can we pinpoint which part of the PCBP2 protein is necessary for HCV replication? To answer these questions, we will employ a number of molecular biology techniques, including protein knockdown, overexpression, expression of truncated PCBP2 proteins, and protein pulldowns. Under these conditions, we will assess the effects of PCBP2 on the production of viral proteins, RNA replication and infectivity. Determining the precise role of PCBP2 in the HCV life cycle will deepen our understanding of the ways in which HCV takes over host cells to further its own replication. The molecular mechanisms uncovered will not only provide new targets for antiviral therapy, but may also be relevant to other important related human pathogens, such as dengue, yellow fever and West Nile viruses.
Program
Doctoral: Vanier Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
339130
Name
Cousineau Sophie E
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Dissecting the role of the poly(C)-binding protein 2 in the hepatitis C virus life cycle
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Hepatitis C Virus; Host-Virus Interactions; Poly(C)-Binding Protein 2 (Pcbp2); Poly-Rc Binding Protein (Pcbp); Protein-Rna Interactions
Abstract
Viruses produce more copies of themselves by taking over the molecular machinery of their host cells. The hepatitis C virus (HCV), which infects an estimated 268 000 Canadians, is no exception. While we know that HCV uses components of human liver cells (i.e. cellular proteins and microRNAs) to promote its own replication and to protect itself from molecular defences against viruses, the precise mechanisms behind many of these interactions are still unknown. This project aims to clarify the role of a particular cellular protein, the poly(C)-binding protein 2 (PCBP2), in the HCV life cycle. HCV is known to co-opt this protein, but it is unclear how PCBP2 helps the virus to accumulate. We aim to understand: At which stage(s) of the virus life cycle does PCBP2 play a role? How does it interact with other cellular elements that we know HCV uses to produce more viruses - specifically, is this a collaboration or a competition? Can we pinpoint which part of the PCBP2 protein is necessary for HCV replication? To answer these questions, we will employ a number of molecular biology techniques, including protein knockdown, overexpression, expression of truncated PCBP2 proteins, and protein pulldowns. Under these conditions, we will assess the effects of PCBP2 on the production of viral proteins, RNA replication and infectivity. Determining the precise role of PCBP2 in the HCV life cycle will deepen our understanding of the ways in which HCV takes over host cells to further its own replication. The molecular mechanisms uncovered will not only provide new targets for antiviral therapy, but may also be relevant to other important related human pathogens, such as dengue, yellow fever and West Nile viruses.
Competitiondate
201511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Cousineau, Sophie E
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~
McGill University - $150,000 Grant (2015-16) | Canada Spends